We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Dermatology

Journal Scan / Research · July 07, 2022

Characterization of Acne Associated With Upadacitinib Treatment in Patients With Moderate to Severe Atopic Dermatitis

Journal of the American Academy of Dermatology


Additional Info

Journal of the American Academy of Dermatology
Characterization of acne associated with upadacitinib treatment in patients with moderate-to-severe atopic dermatitis: a post hoc integrated analysis of three phase 3 randomized, double-blind, placebo-controlled trials
J Am Acad Dermatol 2022 Jun 14;[EPub Ahead of Print], P Mendes-Bastos, B Ladizinski, E Guttman-Yassky, P Jiang, J Liu, VH Prajapati, EL Simpson, N Vigna, HD Teixeira, S Barbarot

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading